Literature DB >> 27887869

A Highly Diverse and Functional Naïve Ubiquitin Variant Library for Generation of Intracellular Affinity Reagents.

Isabel Leung1, Nick Jarvik2, Sachdev S Sidhu3.   

Abstract

We report the design, construction, and validation of a highly diverse phage-displayed naïve ubiquitin variant (Ubv) library. We first conducted a mutation tolerance scan of 27 residues and confirmed that 24 of these could be substituted by chemically diverse amino acids without compromising the display of Ubvs on phage. Subsequently, we constructed a library containing 6.8×1010 unique members, in which these 24 positions were diversified with a degenerate codon that encodes for 6 aa that are prevalent in protein interaction sites. To ensure the optimal structural stability of the Ubvs, we constructed the library in a two-step process, whereby 12 positions were randomized first, and following the selection for displayed Ubvs, the resulting pool was further diversified at the other 12 positions. The resulting library was validated by conducting binding selections against a panel of 40 diverse protein antigens and was found to be as functional as a highly validated synthetic antibody library, yielding binders against 30 of the antigens. Detailed characterization of an Ubv that bound to the cell-surface receptor human epidermal growth factor receptor 3 revealed tight binding in the single-digit nanomolar range. Moreover, Ubvs that bound to two distinct sites on the intracellular adapter Grb2 could be combined to generate a potent inhibitor that functioned in cells. These results validate ubiquitin as a robust scaffold for the construction of naïve libraries that can be used to generate Ubvs that target signaling networks both outside and inside the cells.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  alternative scaffold; combinatorial library; phage display; protein engineering; ubiquitin

Mesh:

Substances:

Year:  2016        PMID: 27887869     DOI: 10.1016/j.jmb.2016.11.016

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Generation of Protein Inhibitors for Validation of Cancer Drug Targets Identified in Functional Genomic Screens.

Authors:  Sherin McDonald; Arunkumar Annan Sudarsan; Hanan Babeker; Kiranmayee Budharaju; Maruti Uppalapati
Journal:  Methods Mol Biol       Date:  2021

2.  A Designer Nanoparticle Platform for Controlled Intracellular Delivery of Bioactive Macromolecules: Inhibition of Ubiquitin-Specific Protease 7 in Breast Cancer Cells.

Authors:  Wynton D McClary; Alexis Catala; Wei Zhang; Fabia Gamboni; Monika Dzieciatkowska; Sachdev S Sidhu; Angelo D'Alessandro; Carlos E Catalano
Journal:  ACS Chem Biol       Date:  2022-07-07       Impact factor: 4.634

3.  A Structure-Based Strategy for Engineering Selective Ubiquitin Variant Inhibitors of Skp1-Cul1-F-Box Ubiquitin Ligases.

Authors:  Maryna Gorelik; Noah Manczyk; Alevtina Pavlenco; Igor Kurinov; Sachdev S Sidhu; Frank Sicheri
Journal:  Structure       Date:  2018-07-19       Impact factor: 5.006

Review 4.  Monobodies and other synthetic binding proteins for expanding protein science.

Authors:  Fern Sha; Gabriel Salzman; Ankit Gupta; Shohei Koide
Journal:  Protein Sci       Date:  2017-03-24       Impact factor: 6.725

5.  Identification and Characterization of Mutations in Ubiquitin Required for Non-covalent Dimer Formation.

Authors:  Mads Gabrielsen; Lori Buetow; Dominika Kowalczyk; Wei Zhang; Sachdev S Sidhu; Danny T Huang
Journal:  Structure       Date:  2019-07-11       Impact factor: 5.006

Review 6.  Emerging drug development technologies targeting ubiquitination for cancer therapeutics.

Authors:  Gianluca Veggiani; María Carla Rosales Gerpe; Sachdev S Sidhu; Wei Zhang
Journal:  Pharmacol Ther       Date:  2019-03-07       Impact factor: 12.310

7.  Rational Development and Characterization of a Ubiquitin Variant with Selectivity for Ubiquitin C-Terminal Hydrolase L3.

Authors:  Chad S Hewitt; Chittaranjan Das; Daniel P Flaherty
Journal:  Biomolecules       Date:  2022-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.